Loading…
Loading…
BDX · NYSE · Healthcare
“At 25.7 times earnings, BDX's valuation appears stretched relative to its modest EPS, demanding careful scrutiny of underlying business fundamentals before consideration.”
— In the voice of Graham
Track upcoming IPOs for the next three months. Filter by sector and expected valuation range.
Market Cap
$45.12B
P/E Ratio
25.68
Forward P/E
—
EPS
$1.34
PEG Ratio
0.93
Book Value
$88.58
Dividend Yield
0.66%
Profit Margin
7.27%
ROE
1.51%
Use the interactive ipo calendar with pre-loaded data for Becton Dickinson & Company. Adjust discount rates, growth assumptions, and projection horizons to model different scenarios.
Pre-loaded inputs for BDX: